Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Synthesis and antiviral evaluation of 3′-substituted thymidine analogues derived from 3′-amino-3′-deoxythymidine — Christophe Pannecouque (1995) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Synthesis and antiviral evaluation of 3′-substituted thymidine analogues derived from 3′-amino-3′-deoxythymidine
Shared by
De Clercq Erik
KU Leuven
Synthesis and antiviral evaluation of 3′-substituted thymidine analogues derived from 3′-amino-3′-deoxythymidine
Article
1995
en
Authors
+3 more
CP
Christophe Pannecouque
RB
Roger Busson
JB
Jan Balzarini
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1995
Synthesis and Antiviral Evaluation of 3′-Substituted Thymidine Analogues Derived from 3′-Amino-3′-deoxythymidine
Christophe Pannecouque
,
K. Van Poppel
,
Jan Balzarini
,
P. Claes
,
De Clercq Erik
,
Piet Herdewijn
Article
1995
ChemInform Abstract: Synthesis and Antiviral Evaluation of 3′‐Substituted Thymidine Analogues Derived from 3′‐Amino‐3′‐deoxythymidine.
Christophe Pannecouque
,
Roger Busson
,
Jan Balzarini
,
P. Claes
,
De Clercq Erik
,
Piet Herdewijn
Article
2011
Synthesis and antiviral evaluation of N9-[2-(phosphonomethoxy)ethyl] (PME) analogues derived from 8-substituted purine
Zlatko Janeba
,
Antonı́n Holý
,
Robert Snoeck
,
Graciela Andreï
,
De Clercq Erik
,
Jan Balzarini
Article
2011
Synthesis and Antiviral Evaluation of N9-[2-(Phosphonomethoxy)ethyl] (PME) Analogues Derived from 8-Substituted Purines
Zlatko Janeba
,
Antonı́n Holý
,
Robert Snoeck
,
Graciela Andreï
,
De Clercq Erik
,
Jan Balzarini
Article
2011
Synthesis and antiviral activity of N9-[3-fluoro-2-(phosphonomethoxy)propyl] analogues derived from N6-substituted adenines and 2,6-diaminopurines
Ondřej Baszczyňski
,
Petr Jansa
,
Martin Dračínský
,
Blanka Klepetářová
,
Antonı́n Holý
,
Ivan Votruba
,
De Clercq Erik
,
Jan Balzarini
,
Zlatko Janeba
Discussion(0)
No comments yet. Be the first to comment.